GL1X · GenesisL1 explorer

MolNFT v1 · #12125 · protein + DNA

Ets-1(331-440)+GGAG duplex

1K7A · DNA (5'- D(*TP*AP*GP*TP*GP*CP*CP*GP*GP*AP*GP*AP*TP*GP*T)-3'): “Ets-1(331-440)+GGAG duplex”. X-ray diffraction, 5 pockets (best druggability 0.50). MolNFT v1 #12125 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1K7A
Type
protein + DNA
Length
267 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA (5'- D(*TP*AP*GP*TP*GP*CP*CP*GP*GP*AP*GP*AP*TP*GP*T)-3'); DNA (5'…
UniProt
P27577
Pockets
5 · best druggability 0.50

Structure

x-ray diffraction · 4 distinct chains · 44% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
B, EDNA (5'- D(*TP*AP*GP*TP*GP*CP*CP*GP*GP*AP*GP*AP*TP*GP*T)-3')dna15——
CDNA (5'- D(*CP*AP*CP*AP*TP*CP*TP*CP*CP*GP*GP*CP*AP*CP*T)-3')dna15——
FDNA (5'- D(*CP*AP*CP*AP*TP*CP*TP*CP*CP*GP*GP*CP*AP*CP*T)-3')dna14——
A, DC-ets-1 proteinprotein10444% helix, 12% strandP27577

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11370.500.8016empty
21100.440.7813empty
3780.430.8021empty
4510.350.8016empty
5900.330.7414empty

Interfaces

6 interfaces between chains.

  • E–F · 645 Ų buried · 63 hydrogen bonds · nucleic-nucleic
  • B–C · 612 Ų buried · 59 hydrogen bonds · nucleic-nucleic
  • B–A · 501 Ų buried · 10 hydrogen bonds · protein-nucleic
  • C–A · 500 Ų buried · 8 hydrogen bonds · protein-nucleic
  • F–D · 487 Ų buried · 10 hydrogen bonds · protein-nucleic

Compared structures

  • 1K7A · Ets-1(331-440)+GGAG duplex · the same entry in another collection · chain D against D, TM-score 1.00
  • P27577 · AlphaFold monomer V2.0 prediction for protein C-ets-1 (P27577) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.